REFRACTORY ACUTE LYMPHOID LEUKEMIA
Clinical trials for REFRACTORY ACUTE LYMPHOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ACUTE LYMPHOID LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY ACUTE LYMPHOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to supercharge Cancer-Fighting cells in tough leukemia cases
Disease control Recruiting nowThis study tests whether adding cytokine-induced killer (CIK) cells can prevent CAR-T cells from wearing out too early in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukemia. Participants will be randomly assigned to receive either standard c…
Matched conditions: REFRACTORY ACUTE LYMPHOID LEUKEMIA
Phase: NA • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
New CAR T-Cell combo shows promise against tough leukemia
Disease control Recruiting nowThis study tests two different CAR T-cell therapy approaches for people with B-cell acute lymphoblastic leukemia that has come back or not responded to treatment. One group gets a combination of two types of CAR T-cells (CD19 and CD22), while the other gets one type (CD19) follow…
Matched conditions: REFRACTORY ACUTE LYMPHOID LEUKEMIA
Phase: NA • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 22, 2026 14:04 UTC